Voya Financial Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $921K | Sell |
1,049
-120
| -10% | -$122K | 0.09% | 96 |
|
|
2025
Q4 | $1.26M | Sell |
1,169
-158
| -12% | -$151K | 0.12% | 82 |
|
|
2025
Q3 | $964K | Sell |
1,327
-103
| -7% | -$76.6K | 0.09% | 99 |
|
|
2025
Q2 | $1.11M | Buy |
1,430
+28
| +2% | +$21.8K | 0.11% | 91 |
|
|
2025
Q1 | $1.15M | Sell |
1,402
-188
| -12% | -$156K | 0.13% | 83 |
|
|
2024
Q4 | $1.23M | Buy |
1,590
+182
| +13% | +$151K | 0.13% | 71 |
|
|
2024
Q3 | $1.24M | Sell |
1,408
-369
| -21% | -$332K | 0.13% | 72 |
|
|
2024
Q2 | $1.62M | Buy |
1,777
+51
| +3% | +$40.8K | 0.18% | 52 |
|
|
2024
Q1 | $1.34M | Sell |
1,726
-202
| -10% | -$144K | 0.15% | 57 |
|
|
2023
Q4 | $1.12M | Buy |
1,928
+145
| +8% | +$84.6K | 0.13% | 66 |
|
|
2023
Q3 | $971K | Sell |
1,783
-12
| -0.7% | -$6.18K | 0.12% | 71 |
|
|
2023
Q2 | $834K | Buy |
1,795
+135
| +8% | +$56.6K | 0.1% | 87 |
|
|
2023
Q1 | $566K | Buy |
1,660
+52
| +3% | +$17.5K | 0.07% | 130 |
|
|
2022
Q4 | $590K | Buy |
1,608
+199
| +14% | +$70.6K | 0.08% | 128 |
|
|
2022
Q3 | $465K | Buy |
1,409
+80
| +6% | +$25.3K | 0.06% | 149 |
|
|
2022
Q2 | $429K | Buy |
1,329
+95
| +8% | +$28.5K | 0.05% | 159 |
|
|
2022
Q1 | $358K | Buy |
+1,234
| New | +$318K | 0.04% | 192 |
|
|
2021
Q2 | – | Sell |
-6,426
| Closed | -$1.19M | – | 459 |
|
|
2021
Q1 | $1.19M | Sell |
6,426
-606
| -9% | -$119K | 0.05% | 263 |
|
|
2020
Q4 | $1.17M | Sell |
7,032
-273
| -4% | -$40.8K | 0.05% | 244 |
|
|
2020
Q3 | $1.07M | Sell |
7,305
-2,854
| -28% | -$442K | 0.05% | 244 |
|
|
2020
Q2 | $1.65M | Sell |
10,159
-2,888
| -22% | -$443K | 0.09% | 176 |
|
|
2020
Q1 | $1.81M | Buy |
13,047
+435
| +3% | +$59.8K | 0.1% | 144 |
|
|
2019
Q4 | $1.66M | Sell |
12,612
-447
| -3% | -$51.8K | 0.08% | 176 |
|
|
2019
Q3 | $1.47M | Buy |
13,059
+1,640
| +14% | +$183K | 0.08% | 179 |
|
|
2019
Q2 | $1.27M | Buy |
11,419
+1,340
| +13% | +$158K | 0.07% | 202 |
|
|
2019
Q1 | $1.3M | Buy |
10,079
+579
| +6% | +$70.4K | 0.08% | 196 |
|
|
2018
Q4 | $1.08M | Buy |
9,500
+819
| +9% | +$91.5K | 0.07% | 199 |
|
|
2018
Q3 | $926K | Buy |
8,681
+2,153
| +33% | +$215K | 0.05% | 249 |
|
|
2018
Q2 | $558K | Buy |
6,528
+1,032
| +19% | +$84.8K | 0.04% | 298 |
|
|
2018
Q1 | $423K | Buy |
5,496
+41
| +0.8% | +$3.3K | 0.03% | 349 |
|
|
2017
Q4 | $464K | Buy |
5,455
+137
| +3% | +$11.7K | 0.03% | 337 |
|
|
2017
Q3 | $452K | Buy |
5,318
+354
| +7% | +$29K | 0.03% | 327 |
|
|
2017
Q2 | $411K | Sell |
4,964
-453
| -8% | -$37K | 0.03% | 326 |
|
|
2017
Q1 | $457K | Buy |
5,417
+518
| +11% | +$41.5K | 0.04% | 303 |
|
|
2016
Q4 | $360K | Buy |
4,899
+417
| +9% | +$31.1K | 0.03% | 337 |
|
|
2016
Q3 | $357K | Sell |
4,482
-162
| -3% | -$13K | 0.04% | 297 |
|
|
2016
Q2 | $363K | Sell |
4,644
-96
| -2% | -$7.23K | 0.04% | 267 |
|
|
2016
Q1 | $340K | Buy |
4,740
+835
| +21% | +$63.2K | 0.05% | 251 |
|
|
2015
Q4 | $337K | Buy |
3,905
+174
| +5% | +$14.4K | 0.05% | 243 |
|
|
2015
Q3 | $300K | Buy |
3,731
+270
| +8% | +$22.8K | 0.05% | 230 |
|
|
2015
Q2 | $290K | Buy |
3,461
+83
| +2% | +$6.32K | 0.05% | 239 |
|
|
2015
Q1 | $250K | Buy |
+3,378
| New | +$240K | 0.05% | 266 |
|
Other funds holding LLY
VCM
VPM
Voya Financial Advisors's LLY Position: Q1 2026 in Review
Voya Financial Advisors reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $122K and leaving 1,049 shares worth $921K. The position accounts for 0.09% of the portfolio, ranked #96.
Voya Financial Advisors first reported a position in LLY in Q1 2015 and has held it in 42 quarters since. The position peaked at $1.81M in Q1 2020. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Voya Financial Advisors held 1,049 shares of Eli Lilly worth $921K as of Q1 2026.
- Voya Financial Advisors sold 120 Eli Lilly shares in Q1 2026, an estimated $122K.
- Eli Lilly made up 0.09% of Voya Financial Advisors's portfolio in Q1 2026, its #96 holding.
- Voya Financial Advisors first reported a position in Eli Lilly in Q1 2015 and has held it in 42 quarters since.
- Voya Financial Advisors's Eli Lilly position peaked at $1.81M in Q1 2020.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.